You are here

Helix BioPharma Corp. Files Clinical Trial Applications for Its Planned European Phase III Efficacy Trial of Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions

Helix BioPharma Corp. Files Clinical Trial Applications for Its Planned European Phase III Efficacy Trial of Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions

Submitted by moderatorj on December 23, 2011 - 5:31pm

Source:

Yahoo/MarketWire

News Tags:

Helix BioPharma

clinical trials

Headline:

Helix BioPharma Corp. Files Clinical Trial Applications for Its Planned European Phase III Efficacy Trial of Topical Interferon Alpha-2b in Patients With Low-Grade Cervical Lesions